CDA and breast cancer: Median CDA activity was 13.20 U/mg protein for the six patients in the matched group, similar to that of RT-treated BC patients (12.00 U/mg protein), but significantly different from that of untreated healthy controls (8.49 U/mg protein) (Supplementary Fig. 4).